Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 11—November 2016
Research

Global Escherichia coli Sequence Type 131 Clade with blaCTX-M-27 Gene

Yasufumi MatsumuraComments to Author , Johann D.D. Pitout, Ryota Gomi, Tomonari Matsuda, Taro Noguchi, Masaki Yamamoto, Gisele Peirano, Rebekah DeVinney, Patricia Bradford, Mary Motyl, Michio Tanaka, Miki Nagao, Shunji Takakura, and Satoshi Ichiyama
Author affiliations: Kyoto University Graduate School of Medicine, Kyoto, Japan (Y. Matsumura, T. Noguchi, M. Yamamoto, M. Tanaka, M. Nagao, S. Takakura, S. Ichiyama); University of Calgary, Calgary, Alberta, Canada (J.D.D. Pitout, G. Peirano, R. DeVinney); Kyoto University Graduate School of Engineering, Kyoto (R. Gomi, T. Matsuda); AstraZeneca Pharmaceuticals LP, Waltham, Massachusetts, USA (P.A. Bradford); Merck & Co., Inc., Rahway, New Jersey, USA (M.R. Motyl)

Main Article

Table

Escherichia coli ST131 isolates included in study of the global expansion of a single clade*

Type of ESBL Country/prefecture of isolation (no. isolates; year)
H30
 H22, n = 2
H30R
 H30, n = 2
H30R, n = 39 H30Rx, n = 18
CTX-M-27, n = 21
 Japan/Kyoto, Shiga, Aichi (13; 2004–2014), Australia (3; 2009, 2010),† United States (2; 2013, 2014),‡ Canada (1; 2008), Thailand (1; 2013), Vietnam (1; 2011)
CTX-M-14, n = 17
 Japan/Kyoto, Shiga, Hyogo (9; 2002–2014), Canada (2; 2005, 2009),† France (1; 2008), New Zealand (1; 2010), South Africa (1; 2008), United States (1; 2008)
 Japan/Kyoto (1; 2009)
Japan/Kyoto (1; 2007)
CTX-M-15, n = 15
Japan/Kyoto, Shiga, Osaka (11; 2006–2014), Canada (2; 2009), UK (1; 2005),§ United States (1; 2008)¶
CTX-M-14 and CTX-M-15, n = 2
Japan/Kyoto (2; 2010, 2014)
CTX-M-2, n = 1
Japan/Kyoto (1; 2004)
TEM, n = 2
Japan/Kyoto 
(2; 2005, 2009)
Negative, n = 3 Japan/Shiga, Hyogo, Osaka 
(3; 2014)

*ESBL, extended-spectrum β-lactamase; ST, sequence type.
†Raw reads were downloaded from European Nucleotide Archive (accession no. ERA118286) for 3 isolates from Australia (S100EC, S107EC, S108EC) and 1 isolate from Canada (S135EC).
‡MRSN17749 draft genome (GenBank assembly accession no. GCA_000770275.1) and IEH71520 draft genome (GenBank assembly accession no. GCA_000681435.1).
§EC958 complete genome (GenBank assembly accession no. GCA_000285655.3).
¶JJ1886 complete genome (GenBank assembly accession no. GCA_000493755.1).

Main Article

Page created: October 18, 2016
Page updated: October 18, 2016
Page reviewed: October 18, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external